Search research articles
Contact Us
Filters
Showing results (111-120 of 214) with videos related to
Page
of 22
Sort By:
Journal of Lipid Research
|
December 2, 2005
Increased sphingomyelin content impairs HDL biogenesis and maturation in human Niemann-Pick disease type B
Ching Yin Lee, Alain Lesimple, Maxime Denis, et al.
European Heart Journal
|
November 7, 2017
Desmocollin 1 is abundantly expressed in atherosclerosis and impairs high-density lipoprotein biogenesis
Hong Y Choi, Isabelle Ruel, Abba Malina, et al.
Angiology
|
April 24, 2015
Reducing Vascular Calcification by Anti-IL-1β Monoclonal Antibody in a Mouse Model of Familial Hypercholesterolemia
Zuhier Awan, Maxime Denis, Anna Roubtsova, et al.
Journal of Clinical Lipidology
|
February 25, 2025
Polygenic risk score for coronary artery disease predicts atherosclerotic cardiovascular disease in familial hypercholesterolemia
Martine Paquette, Mark Trinder, Isabelle Ruel, et al.
The Journal of Biological Chemistry
|
January 26, 2008
Quantitative analysis of ABCA1-dependent compartmentalization and trafficking of apolipoprotein A-I: implications for determining cellular kinetics of nascent high density lipoprotein biogenesis
Houssein Hajj Hassan, Dana Bailey, Dong-Young Donna Lee, et al.
Journal of Lipid Research
|
July 28, 2007
Identification of an ABCA1-dependent phospholipid-rich plasma membrane apolipoprotein A-I binding site for nascent HDL formation: implications for current models of HDL biogenesis
Houssein Hajj Hassan, Maxime Denis, Dong-Young Donna Lee, et al.
European Journal of Preventive Cardiology
|
April 15, 2026
Integration of a polygenic score into clinical risk prediction of atherosclerotic cardiovascular disease in familial hypercholesterolemia
Martine Paquette, Mark Trinder, Isabelle Ruel, et al.
Circulation. Cardiovascular Quality and Outcomes
|
August 26, 2010
Rosuvastatin for primary prevention among individuals with elevated high-sensitivity c-reactive protein and 5% to 10% and 10% to 20% 10-year risk. Implications of the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial for "intermediate risk"
Paul M Ridker, Jean G Macfadyen, Børge G Nordestgaard, et al.
Journal of Clinical Lipidology
|
April 1, 2023
Metabolic syndrome predicts cardiovascular risk and mortality in familial hypercholesterolemia
Martine Paquette, Sophie Bernard, Bertrand Cariou, et al.
BMC Pregnancy and Childbirth
|
November 15, 2011
Smoking in preeclamptic women is associated with higher birthweight for gestational age and lower soluble fms-like tyrosine kinase-1 levels: a nested case control study
Susan R Kahn, Nisha D Almeida, Helen McNamara, et al.
Page
of 22
Search research articles
Search
Showing results (111-120 of 214) with videos related to
Sort By:
Page
of 22
Journal of Lipid Research
|
December 2, 2005
Increased sphingomyelin content impairs HDL biogenesis and maturation in human Niemann-Pick disease type B
Ching Yin Lee, Alain Lesimple, Maxime Denis, et al.
European Heart Journal
|
November 7, 2017
Desmocollin 1 is abundantly expressed in atherosclerosis and impairs high-density lipoprotein biogenesis
Hong Y Choi, Isabelle Ruel, Abba Malina, et al.
Angiology
|
April 24, 2015
Reducing Vascular Calcification by Anti-IL-1β Monoclonal Antibody in a Mouse Model of Familial Hypercholesterolemia
Zuhier Awan, Maxime Denis, Anna Roubtsova, et al.
Journal of Clinical Lipidology
|
February 25, 2025
Polygenic risk score for coronary artery disease predicts atherosclerotic cardiovascular disease in familial hypercholesterolemia
Martine Paquette, Mark Trinder, Isabelle Ruel, et al.
The Journal of Biological Chemistry
|
January 26, 2008
Quantitative analysis of ABCA1-dependent compartmentalization and trafficking of apolipoprotein A-I: implications for determining cellular kinetics of nascent high density lipoprotein biogenesis
Houssein Hajj Hassan, Dana Bailey, Dong-Young Donna Lee, et al.
Journal of Lipid Research
|
July 28, 2007
Identification of an ABCA1-dependent phospholipid-rich plasma membrane apolipoprotein A-I binding site for nascent HDL formation: implications for current models of HDL biogenesis
Houssein Hajj Hassan, Maxime Denis, Dong-Young Donna Lee, et al.
European Journal of Preventive Cardiology
|
April 15, 2026
Integration of a polygenic score into clinical risk prediction of atherosclerotic cardiovascular disease in familial hypercholesterolemia
Martine Paquette, Mark Trinder, Isabelle Ruel, et al.
Circulation. Cardiovascular Quality and Outcomes
|
August 26, 2010
Rosuvastatin for primary prevention among individuals with elevated high-sensitivity c-reactive protein and 5% to 10% and 10% to 20% 10-year risk. Implications of the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial for "intermediate risk"
Paul M Ridker, Jean G Macfadyen, Børge G Nordestgaard, et al.
Journal of Clinical Lipidology
|
April 1, 2023
Metabolic syndrome predicts cardiovascular risk and mortality in familial hypercholesterolemia
Martine Paquette, Sophie Bernard, Bertrand Cariou, et al.
BMC Pregnancy and Childbirth
|
November 15, 2011
Smoking in preeclamptic women is associated with higher birthweight for gestational age and lower soluble fms-like tyrosine kinase-1 levels: a nested case control study
Susan R Kahn, Nisha D Almeida, Helen McNamara, et al.
Page
of 22